BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28154176)

  • 21. Guanine-nucleotide binding activity, interaction with GTPase-activating protein and solution conformation of the human c-Ha-Ras protein catalytic domain are retained upon deletion of C-terminal 18 amino acid residues.
    Fujita-Yoshigaki J; Ito Y; Yamasaki K; Muto Y; Miyazawa T; Nishimura S; Yokoyama S
    J Protein Chem; 1992 Dec; 11(6):731-9. PubMed ID: 1466766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KRAS Switch Mutants D33E and A59G Crystallize in the State 1 Conformation.
    Lu J; Bera AK; Gondi S; Westover KD
    Biochemistry; 2018 Jan; 57(3):324-333. PubMed ID: 29235861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformational states of human rat sarcoma (Ras) protein complexed with its natural ligand GTP and their role for effector interaction and GTP hydrolysis.
    Spoerner M; Hozsa C; Poetzl JA; Reiss K; Ganser P; Geyer M; Kalbitzer HR
    J Biol Chem; 2010 Dec; 285(51):39768-78. PubMed ID: 20937837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homogeneous Dual-Parametric-Coupled Assay for Simultaneous Nucleotide Exchange and KRAS/RAF-RBD Interaction Monitoring.
    Kopra K; Vuorinen E; Abreu-Blanco M; Wang Q; Eskonen V; Gillette W; Pulliainen AT; Holderfield M; Härmä H
    Anal Chem; 2020 Apr; 92(7):4971-4979. PubMed ID: 32106676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
    Boissier P; Huynh-Do U
    Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of a novel fluorescent GTP analogue with the small G-protein K-Ras.
    Iwata S; Masuhara K; Umeki N; Sako Y; Maruta S
    J Biochem; 2016 Jan; 159(1):41-8. PubMed ID: 26184075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic mechanisms of mutation-dependent Harvey Ras activation and their relevance for the development of Costello syndrome.
    Wey M; Lee J; Jeong SS; Kim J; Heo J
    Biochemistry; 2013 Nov; 52(47):8465-79. PubMed ID: 24224811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the GTP-binding/GTPase cycle of Cdc42Hs using extrinsic reporter group fluorescence.
    Nomanbhoy TK; Leonard DA; Manor D; Cerione RA
    Biochemistry; 1996 Apr; 35(14):4602-8. PubMed ID: 8605211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternate mechanisms of ras activation are complementary and favor and formation of ras-GTP.
    Patel G; MacDonald MJ; Khosravi-Far R; Hisaka MM; Der CJ
    Oncogene; 1992 Feb; 7(2):283-8. PubMed ID: 1549350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NMR in integrated biophysical drug discovery for RAS: past, present, and future.
    Marshall CB; KleinJan F; Gebregiworgis T; Lee KY; Fang Z; Eves BJ; Liu NF; Gasmi-Seabrook GMC; Enomoto M; Ikura M
    J Biomol NMR; 2020 Nov; 74(10-11):531-554. PubMed ID: 32804298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-dimensional structure of p21H-ras and its implications.
    Wittinghofer F
    Semin Cancer Biol; 1992 Aug; 3(4):189-98. PubMed ID: 1421163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of guanosine triphosphate hydrolysis by Ras and Ras-GAP proteins as rationalized by ab initio QM/MM simulations.
    Grigorenko BL; Nemukhin AV; Shadrina MS; Topol IA; Burt SK
    Proteins; 2007 Feb; 66(2):456-66. PubMed ID: 17094109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of KRAS-GTPase Activity.
    Rabara D; Stephen AG
    Methods Mol Biol; 2024; 2797():91-102. PubMed ID: 38570454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural basis of the oncogenic KRAS mutant and GJ101 complex.
    Kim HJ; Han CW; Jeong MS; Jang SB
    Biochem Biophys Res Commun; 2023 Jan; 641():27-33. PubMed ID: 36516586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ras activation revisited: role of GEF and GAP systems.
    Hennig A; Markwart R; Esparza-Franco MA; Ladds G; Rubio I
    Biol Chem; 2015 Aug; 396(8):831-48. PubMed ID: 25781681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors.
    Gebregiworgis T; Kano Y; St-Germain J; Radulovich N; Udaskin ML; Mentes A; Huang R; Poon BPK; He W; Valencia-Sama I; Robinson CM; Huestis M; Miao J; Yeh JJ; Zhang ZY; Irwin MS; Lee JE; Tsao MS; Raught B; Marshall CB; Ohh M; Ikura M
    Nat Commun; 2021 Nov; 12(1):6274. PubMed ID: 34725361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linear free energy relationships in the intrinsic and GTPase activating protein-stimulated guanosine 5'-triphosphate hydrolysis of p21ras.
    Schweins T; Geyer M; Kalbitzer HR; Wittinghofer A; Warshel A
    Biochemistry; 1996 Nov; 35(45):14225-31. PubMed ID: 8916907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ras activation in response to phorbol ester proceeds independently of the EGFR via an unconventional nucleotide-exchange factor system in COS-7 cells.
    Rubio I; Rennert K; Wittig U; Beer K; Dürst M; Stang SL; Stone J; Wetzker R
    Biochem J; 2006 Sep; 398(2):243-56. PubMed ID: 16709153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro GEF and GAP assays.
    Eberth A; Ahmadian MR
    Curr Protoc Cell Biol; 2009 Jun; Chapter 14():Unit 14.9. PubMed ID: 19499504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The isolated catalytic hairpin of the Ras-specific guanine nucleotide exchange factor Cdc25Mm retains nucleotide dissociation activity but has impaired nucleotide exchange activity.
    Sacco E; Fantinato S; Manzoni R; Metalli D; De Gioia L; Fantucci P; Alberghina L; Vanoni M
    FEBS Lett; 2005 Dec; 579(30):6851-8. PubMed ID: 16325815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.